Postnatal depression clinical manifestations and treatment options

Abstract

Postnatal depression is a major public health concern, with a global prevalence estimated between 10% and 20%. Early identification and effective management of postnatal depression are essential for the mother's mental health and the child's optimal development, reducing long-term associated risks. Analysis of the specialized literature concerning the clinical characteristics of postnatal depression, as well as the identification of appropriate and effective treatment options. The study involved a systematic literature review, selecting relevant articles from databases : PubMed, Scopus, NCBI, and Web of Science. A total of 31 scientific articles published in the last five years were analyzed, covering both theoretical aspects and clinical research on risk factors, clinical manifestations, and therapeutic strategies. The analysis revealed that the main symptoms of postnatal depression include persistent sadness, anhedonia, emotional lability, insomnia, chronic fatigue, irritability, anxiety, sudden outbursts of anger, feelings of guilt, suicidal thoughts, fear of harming the child or oneself, and a lack of interest in the infant. In mild forms of postnatal depression, brief psychological interventions and psychotherapy are generally recommended, while in moderate to severe cases, first-line treatment is pharmacological—preferably with a selective serotonin reuptake inhibitor. Electroconvulsive therapy is indicated in treatment-resistant depression. Postnatal depression presents with a broad spectrum of clinical manifestations, reflecting varying degrees of severity. Accurate identification of these forms allows for optimized therapeutic strategies and individualized interventions tailored to the patient’s clinical needs.